The protein encoded by this gene is a member of the tripartite motif (TRIM) family, also known as the 'RING-B box-coiled coil' (RBCC) subgroup of RING finger proteins. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. This protein forms homodimers which associate with microtubules in the cytoplasm. The protein is likely involved in the formation of multiprotein structures acting as anchor points to microtubules. Mutations in this gene have been associated with the X-linked form of Opitz syndrome, which is characterized by midline abnormalities such as cleft lip, laryngeal cleft, heart defects, hypospadias, and agenesis of the corpus callosum. This gene was also the first example of a gene subject to X inactivation in human while escaping it in mouse. Several different transcript variants are generated by alternate splicing; however, the full length nature of two variants has not been determined.
^Quaderi NA, Schweiger S, Gaudenz K, Franco B, Rugarli EI, Berger W, Feldman GJ, Volta M, Andolfi G, Gilgenkrantz S, Marion RW, Hennekam RC, Opitz JM, Muenke M, Ropers HH, Ballabio A (Dec 1997). "Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22". Nat Genet17 (3): 285–91. doi:10.1038/ng1197-285. PMID9354791.
^Perry J, Feather S, Smith A, Palmer S, Ashworth A (Mar 1998). "The human FXY gene is located within Xp22.3: implications for evolution of the mammalian X chromosome". Hum Mol Genet7 (2): 299–305. doi:10.1093/hmg/7.2.299. PMID9425238.
De Falco F, Cainarca S, Andolfi G, et al. (2004). "X-linked Opitz syndrome: novel mutations in the MID1 gene and redefinition of the clinical spectrum". Am. J. Med. Genet. A120 (2): 222–8. doi:10.1002/ajmg.a.10265. PMID12833403.
Robin NH, Feldman GJ, Aronson AL, et al. (1996). "Opitz syndrome is genetically heterogeneous, with one locus on Xp22, and a second locus on 22q11.2". Nat. Genet.11 (4): 459–61. doi:10.1038/ng1295-459. PMID7493033.
Van den Veyver IB, Cormier TA, Jurecic V, et al. (1998). "Characterization and physical mapping in human and mouse of a novel RING finger gene in Xp22". Genomics51 (2): 251–61. doi:10.1006/geno.1998.5350. PMID9722948.
Cainarca S, Messali S, Ballabio A, Meroni G (1999). "Functional characterization of the Opitz syndrome gene product (midin): evidence for homodimerization and association with microtubules throughout the cell cycle". Hum. Mol. Genet.8 (8): 1387–96. doi:10.1093/hmg/8.8.1387. PMID10400985.
Cox TC, Allen LR, Cox LL, et al. (2000). "New mutations in MID1 provide support for loss of function as the cause of X-linked Opitz syndrome". Hum. Mol. Genet.9 (17): 2553–62. doi:10.1093/hmg/9.17.2553. PMID11030761.
Trockenbacher A, Suckow V, Foerster J, et al. (2001). "MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation". Nat. Genet.29 (3): 287–94. doi:10.1038/ng762. PMID11685209.
Landry JR, Mager DL (2003). "Widely spaced alternative promoters, conserved between human and rodent, control expression of the Opitz syndrome gene MID1". Genomics80 (5): 499–508. doi:10.1016/S0888-7543(02)96863-1. PMID12408967.
Winter J, Lehmann T, Krauss S, et al. (2004). "Regulation of the MID1 protein function is fine-tuned by a complex pattern of alternative splicing". Hum. Genet.114 (6): 541–52. doi:10.1007/s00439-004-1114-x. PMID15057556.